Table 1

Clinical data

ALSFR-SMuscular testing
PatientOnsetDuration
(months)
El Escorial
criteria
AtrophyTotal
(/48)
Hand
(/4)
Total
(/150)
UL
(/45)
Hand
(/10)
1.M.68UL74Probable+421148438
2.M.50UL28Probable+421145405
3.M.54LL28Probable+414120418
4.M.59LL24Probable+343102397
5.M.62B12Probable+433147449
6.M.48UL23Probable+392145428
7.M.61LL33Probable+394105438
8.M.44LL21Probable404131449
9.F.76LL26Lab-supported344105418
10.M.66UL34Probable+372144416
11.M.45B15Definite+311137418
12.M.55LL58Probable+30279386
13.F.37UL39Probable+413140396
14.M.51UL10Probable+454134438
15.M.52UL15Lab-supported+464145408
16.F.50UL14Probable+444145449
17.F.56UL15Probable+403144427
18.M.58LL43Probable+333114428
19.F.62LL8Probable403145428
20.M.65UL17Probable+453145408
21.M.63LL19Lab-supported+403129438
  • Patient: rank.gender (F, female; M, male).age (years old); Onset: first clinical signs manifested in upper limb (UL) or lower limb (LL) or bulbar (B); Duration of the disease in months; El Escorial criteria for amyotrophic lateral sclerosis (ALS): definite ALS (Definite), clinically probable ALS (Probable), Clinically probable—laboratory supported ALS (Lab-supported); Atrophy observed (+) or not (−) on the side explored during the electrophysiological investigations; ALSFR-S: total score of the revised ALS functional resting scale (Total/maximal score 48) and for handwriting (Hand/4); Muscular testing: in upper and lower limbs and in the neck (Total/150), on the side explored during the electrophysiological investigations (UL/45) and in intrinsic hand muscles (Hand/10).